US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
US4881175A
(en)
|
1986-09-02 |
1989-11-14 |
Genex Corporation |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
US5580737A
(en)
|
1990-06-11 |
1996-12-03 |
Nexstar Pharmaceuticals, Inc. |
High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
|
US7150982B2
(en)
|
1991-09-09 |
2006-12-19 |
Third Wave Technologies, Inc. |
RNA detection assays
|
US6872816B1
(en)
|
1996-01-24 |
2005-03-29 |
Third Wave Technologies, Inc. |
Nucleic acid detection kits
|
US5443505A
(en)
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
US5651981A
(en)
|
1994-03-29 |
1997-07-29 |
Northwestern University |
Cationic phospholipids for transfection
|
JP4118327B2
(ja)
|
1994-08-20 |
2008-07-16 |
ゲンダック・リミテッド |
Dna認識のための結合タンパク質におけるまたはそれに関連する改良
|
US5767099A
(en)
|
1994-12-09 |
1998-06-16 |
Genzyme Corporation |
Cationic amphiphiles containing amino acid or dervatized amino acid groups for intracellular delivery of therapeutic molecules
|
US5725493A
(en)
|
1994-12-12 |
1998-03-10 |
Avery; Robert Logan |
Intravitreal medicine delivery
|
US6057153A
(en)
|
1995-01-13 |
2000-05-02 |
Yale University |
Stabilized external guide sequences
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
US5830430A
(en)
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
US5851548A
(en)
|
1995-06-07 |
1998-12-22 |
Gen-Probe Incorporated |
Liposomes containing cationic lipids and vitamin D
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
US6203986B1
(en)
|
1998-10-22 |
2001-03-20 |
Robert H. Singer |
Visualization of RNA in living cells
|
ATE383331T1
(de)
|
1998-11-12 |
2008-01-15 |
Invitrogen Corp |
Transportreagentien
|
EP1154691A4
(en)
|
1999-01-05 |
2004-07-07 |
Massachusetts Eye & Ear Infirm |
TARGETED ADMINISTRATION OF REGULATED RELEASE MEDICINE TO RETINA AND CHOROID THROUGH SCLEROTIC
|
US6599692B1
(en)
|
1999-09-14 |
2003-07-29 |
Sangamo Bioscience, Inc. |
Functional genomics using zinc finger proteins
|
US6534261B1
(en)
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
US7013219B2
(en)
|
1999-01-12 |
2006-03-14 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
US20090130718A1
(en)
|
1999-02-04 |
2009-05-21 |
Diversa Corporation |
Gene site saturation mutagenesis
|
US20020164575A1
(en)
|
1999-09-14 |
2002-11-07 |
Sangamo Biosciences, Inc., A Delaware Corporation |
Gene identification
|
US6416777B1
(en)
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
CN1292721C
(zh)
|
1999-10-21 |
2007-01-03 |
爱尔康公司 |
药物释放装置
|
WO2001040798A2
(en)
|
1999-12-06 |
2001-06-07 |
Sangamo Biosciences, Inc. |
Methods of using randomized libraries of zinc finger proteins for the identification of gene function
|
ATE427994T1
(de)
|
2000-04-12 |
2009-04-15 |
Dana Farber Cancer Inst Inc |
Selbstlíschende rekombinasen, dafur kodierende nukleinsauren und verfahren zu deren verwendung
|
US6511808B2
(en)
|
2000-04-28 |
2003-01-28 |
Sangamo Biosciences, Inc. |
Methods for designing exogenous regulatory molecules
|
WO2001083793A2
(en)
|
2000-04-28 |
2001-11-08 |
Sangamo Biosciences, Inc. |
Targeted modification of chromatin structure
|
WO2002089767A1
(en)
|
2001-05-03 |
2002-11-14 |
Massachusetts Eye And Ear Infirmary |
Implantable drug delivery device and use thereof
|
AU2003219847A1
(en)
|
2002-02-21 |
2003-09-09 |
The Wistar Institute Of Anatomy And Biology |
Methods and compositions for reversibly controlling expression of target genes in cells
|
US20070020627A1
(en)
|
2002-06-11 |
2007-01-25 |
The Scripps Research Institute |
Artificial transcription factors
|
EP2322535A3
(en)
|
2002-09-20 |
2011-09-28 |
Yale University |
Riboswitches, methods for their use, and compositions for use with riboswitches
|
WO2004099366A2
(en)
|
2002-10-23 |
2004-11-18 |
The General Hospital Corporation |
Context sensitive parallel optimization of zinc finger dna binding domains
|
US7021555B2
(en)
|
2004-01-06 |
2006-04-04 |
Zoo Med Laboratories, Inc. |
Spraying/misting for plants and animals
|
US8053232B2
(en)
|
2004-01-23 |
2011-11-08 |
Virxsys Corporation |
Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing
|
US7919277B2
(en)
|
2004-04-28 |
2011-04-05 |
Danisco A/S |
Detection and typing of bacterial strains
|
WO2006002547A1
(en)
|
2004-07-06 |
2006-01-12 |
UNIVERSITé DE SHERBROOKE |
A target-dependent nucleic acid adapter
|
WO2006023207A2
(en)
|
2004-08-19 |
2006-03-02 |
The United States Of America As Represented By The Secretary Of Health And Human Services, Nih |
Coacervate of anionic and cationic polymer forming microparticles for the sustained release of therapeutic agents
|
US9315862B2
(en)
|
2004-10-05 |
2016-04-19 |
California Institute Of Technology |
Aptamer regulated nucleic acids and uses thereof
|
HUE027400T2
(en)
|
2005-02-18 |
2016-10-28 |
Glaxosmithkline Biologicals Sa |
Proteins and nucleic acids from meningitis / sepsis with Escherichia coli
|
JP2006248978A
(ja)
|
2005-03-10 |
2006-09-21 |
Mebiopharm Co Ltd |
新規なリポソーム製剤
|
US20100055793A1
(en)
|
2005-07-25 |
2010-03-04 |
Johns Hopkins University |
Site-specific modification of the human genome using custom-designed zinc finger nucleases
|
SG10201508995QA
(en)
|
2005-07-26 |
2015-11-27 |
Sangamo Biosciences Inc |
Targeted integration and expression of exogenous nucleic acid sequences
|
WO2007025097A2
(en)
|
2005-08-26 |
2007-03-01 |
Danisco A/S |
Use
|
AU2012244264B2
(en)
|
2005-08-26 |
2015-08-06 |
Dupont Nutrition Biosciences Aps |
Use
|
WO2007106690A2
(en)
|
2006-03-15 |
2007-09-20 |
Siemens Healthcare Diagnostics Inc. |
Degenerate nucleobase analogs
|
DK2426220T3
(en)
|
2006-05-19 |
2016-09-26 |
Dupont Nutrition Biosci Aps |
Labeled microorganisms, and methods for labeling
|
CA2651494C
(en)
|
2006-05-25 |
2015-09-29 |
Sangamo Biosciences, Inc. |
Engineered cleavage half-domains
|
US9150626B2
(en)
|
2006-06-02 |
2015-10-06 |
President And Fellows Of Harvard College |
Protein surface remodeling
|
ES2610811T3
(es)
|
2006-06-16 |
2017-05-03 |
Dupont Nutrition Biosciences Aps |
Bacteria Streptococcus thermophilus
|
US9201063B2
(en)
|
2006-11-16 |
2015-12-01 |
General Electric Company |
Sequential analysis of biological samples
|
EP2126130B1
(en)
|
2007-03-02 |
2015-03-25 |
DuPont Nutrition Biosciences ApS |
Cultures with improved phage resistance
|
US8153863B2
(en)
|
2007-03-23 |
2012-04-10 |
New York University |
Transgenic plants expressing GLK1 and CCA1 having increased nitrogen assimilation capacity
|
JP5258874B2
(ja)
|
2007-04-10 |
2013-08-07 |
キアゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Rna干渉タグ
|
WO2008151032A2
(en)
|
2007-05-31 |
2008-12-11 |
Washington University In St. Louis |
Arrays and methods comprising m. smithii gene products
|
BRPI0817312B1
(pt)
|
2007-09-25 |
2018-05-29 |
Pastoral Greenhouse Gas Research Limited |
Métodos de inibição de uma célula metanógena, e composição farmacêutica
|
US9029524B2
(en)
|
2007-12-10 |
2015-05-12 |
California Institute Of Technology |
Signal activated RNA interference
|
FR2925918A1
(fr)
|
2007-12-28 |
2009-07-03 |
Pasteur Institut |
Typage et sous-typage moleculaire de salmonella par identification des sequences nucleotidiques variables des loci crispr
|
WO2009146179A1
(en)
|
2008-04-15 |
2009-12-03 |
University Of Iowa Research Foundation |
Zinc finger nuclease for the cftr gene and methods of use thereof
|
CA2725601A1
(en)
|
2008-04-28 |
2009-11-05 |
President And Fellows Of Harvard College |
Supercharged proteins for cell penetration
|
JP2010017179A
(ja)
|
2008-06-11 |
2010-01-28 |
Sumitomo Chemical Co Ltd |
Dnaを定量又は検出する方法
|
JP2010017178A
(ja)
|
2008-06-11 |
2010-01-28 |
Sumitomo Chemical Co Ltd |
Dnaを定量又は検出する方法
|
US8546553B2
(en)
|
2008-07-25 |
2013-10-01 |
University Of Georgia Research Foundation, Inc. |
Prokaryotic RNAi-like system and methods of use
|
JP2010048566A
(ja)
|
2008-08-19 |
2010-03-04 |
Sumitomo Chemical Co Ltd |
Dnaを定量又は検出する方法
|
JP2010068800A
(ja)
|
2008-08-19 |
2010-04-02 |
Sumitomo Chemical Co Ltd |
Dnaを定量又は検出する方法
|
EP2159286A1
(en)
|
2008-09-01 |
2010-03-03 |
Consiglio Nazionale Delle Ricerche |
Method for obtaining oligonucleotide aptamers and uses thereof
|
EP2331071A1
(en)
|
2008-09-05 |
2011-06-15 |
Institut National De La Sante Et De La Recherche Medicale |
Novel multimodular assembly useful for intracellular delivery
|
US8636884B2
(en)
|
2008-09-15 |
2014-01-28 |
Abbott Diabetes Care Inc. |
Cationic polymer based wired enzyme formulations for use in analyte sensors
|
US20100076057A1
(en)
|
2008-09-23 |
2010-03-25 |
Northwestern University |
TARGET DNA INTERFERENCE WITH crRNA
|
US9115386B2
(en)
|
2008-09-26 |
2015-08-25 |
Children's Medical Center Corporation |
Selective oxidation of 5-methylcytosine by TET-family proteins
|
AU2009306206B2
(en)
|
2008-10-21 |
2015-10-08 |
Animal Health Trust |
Diagnostic test for Streptococcus equi
|
US9404098B2
(en)
|
2008-11-06 |
2016-08-02 |
University Of Georgia Research Foundation, Inc. |
Method for cleaving a target RNA using a Cas6 polypeptide
|
US10662227B2
(en)
|
2008-11-07 |
2020-05-26 |
Dupont Nutrition Biosciences Aps |
Bifidobacteria CRISPR sequences
|
AR075356A1
(es)
|
2008-11-10 |
2011-03-30 |
Two Blades Foundation |
Promotores inducibles por patogenos y su uso en el mejoramiento de la resistencia a las enfermedades en plantas
|
RU2570557C2
(ru)
|
2008-11-11 |
2015-12-10 |
Алиментари Хелс Лимитед |
ПРОБИОТИЧЕСКАЯ БИФИДОБАКТЕРИЯ Bifidobacterium Longum
|
GB2466177A
(en)
|
2008-12-03 |
2010-06-16 |
Arab Science & Technology Found |
Bacteriophage selection and breeding
|
US20110016540A1
(en)
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of genes associated with trinucleotide repeat expansion disorders in animals
|
AU2009325069B2
(en)
|
2008-12-11 |
2015-03-19 |
Pacific Biosciences Of California, Inc. |
Classification of nucleic acid templates
|
US9175338B2
(en)
|
2008-12-11 |
2015-11-03 |
Pacific Biosciences Of California, Inc. |
Methods for identifying nucleic acid modifications
|
DK2367938T3
(da)
|
2008-12-12 |
2014-08-25 |
Dupont Nutrition Biosci Aps |
Genetisk cluster af stammer af streptococcus thermophilus med unikke rheologiske egenskaber til mælkefermentering
|
WO2010075424A2
(en)
|
2008-12-22 |
2010-07-01 |
The Regents Of University Of California |
Compositions and methods for downregulating prokaryotic genes
|
US8389679B2
(en)
|
2009-02-05 |
2013-03-05 |
The Regents Of The University Of California |
Targeted antimicrobial moieties
|
KR20100093626A
(ko)
|
2009-02-17 |
2010-08-26 |
서강대학교산학협력단 |
슈도모나스 애루지노사에 대한 파아지 치료
|
CN102421897B
(zh)
|
2009-03-06 |
2015-12-16 |
合成基因组股份有限公司 |
用于克隆和操作基因组的方法
|
US8501405B2
(en)
|
2009-04-27 |
2013-08-06 |
Pacific Biosciences Of California, Inc. |
Real-time sequencing methods and systems
|
JP2012525146A
(ja)
|
2009-04-28 |
2012-10-22 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
細胞透過のための過剰に荷電されたタンパク質
|
WO2010132092A2
(en)
|
2009-05-12 |
2010-11-18 |
The Scripps Research Institute |
Cytidine deaminase fusions and related methods
|
US9063156B2
(en)
|
2009-06-12 |
2015-06-23 |
Pacific Biosciences Of California, Inc. |
Real-time analytical methods and systems
|
US8569256B2
(en)
|
2009-07-01 |
2013-10-29 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
EP2287323A1
(en)
|
2009-07-31 |
2011-02-23 |
Association Institut de Myologie |
Widespread gene delivery to the retina using systemic administration of AAV vectors
|
US20120178647A1
(en)
|
2009-08-03 |
2012-07-12 |
The General Hospital Corporation |
Engineering of zinc finger arrays by context-dependent assembly
|
NZ598457A
(en)
|
2009-08-03 |
2014-06-27 |
Recombinetics Inc |
Methods and compositions for targeted gene modification
|
GB0913681D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
US8889394B2
(en)
|
2009-09-07 |
2014-11-18 |
Empire Technology Development Llc |
Multiple domain proteins
|
AU2010299857A1
(en)
|
2009-09-25 |
2012-04-19 |
Basf Plant Science Company Gmbh |
Plants having enhanced yield-related traits and a method for making the same
|
US9677125B2
(en)
|
2009-10-21 |
2017-06-13 |
General Electric Company |
Detection of plurality of targets in biological samples
|
US20110269119A1
(en)
|
2009-10-30 |
2011-11-03 |
Synthetic Genomics, Inc. |
Encoding text into nucleic acid sequences
|
CA2779495C
(en)
|
2009-10-30 |
2019-04-30 |
Synthetic Genomics, Inc. |
Encoding text into nucleic acid sequences
|
DK3202898T3
(en)
|
2009-11-02 |
2019-01-14 |
Univ Washington |
THERAPEUTIC NUCLEASE COMPOSITIONS AND PROCEDURES
|
US20120315670A1
(en)
|
2009-11-02 |
2012-12-13 |
Gen9, Inc. |
Compositions and Methods for the Regulation of Multiple Genes of Interest in a Cell
|
US20110104787A1
(en)
|
2009-11-05 |
2011-05-05 |
President And Fellows Of Harvard College |
Fusion Peptides That Bind to and Modify Target Nucleic Acid Sequences
|
US20110142886A1
(en)
|
2009-12-01 |
2011-06-16 |
Intezyne Technologies, Incorporated |
Pegylated polyplexes for polynucleotide delivery
|
EP2531891B1
(en)
|
2010-02-05 |
2020-04-15 |
Canon Kabushiki Kaisha |
Negative photosensitive resin composition, pattern formation method, and liquid discharge head
|
PT2534173T
(pt)
|
2010-02-08 |
2019-10-31 |
Sangamo Therapeutics Inc |
Semidomínios de clivagem manipulados
|
US20120027786A1
(en)
|
2010-02-23 |
2012-02-02 |
Massachusetts Institute Of Technology |
Genetically programmable pathogen sense and destroy
|
EP2542676A1
(en)
|
2010-03-05 |
2013-01-09 |
Synthetic Genomics, Inc. |
Methods for cloning and manipulating genomes
|
US10087431B2
(en)
|
2010-03-10 |
2018-10-02 |
The Regents Of The University Of California |
Methods of generating nucleic acid fragments
|
EP2545161B1
(en)
|
2010-03-12 |
2015-09-23 |
Brookhaven Science Associates, LLC |
Method of using enterobacter sp. 638
|
WO2011123830A2
(en)
|
2010-04-02 |
2011-10-06 |
Amunix Operating Inc. |
Alpha 1-antitrypsin compositions and methods of making and using same
|
CN103038338B
(zh)
|
2010-05-10 |
2017-03-08 |
加利福尼亚大学董事会 |
核糖核酸内切酶组合物及其使用方法
|
EP3156062A1
(en)
|
2010-05-17 |
2017-04-19 |
Sangamo BioSciences, Inc. |
Novel dna-binding proteins and uses thereof
|
GB201008267D0
(en)
|
2010-05-18 |
2010-06-30 |
Univ Edinburgh |
Cationic lipids
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
WO2011153120A1
(en)
|
2010-06-04 |
2011-12-08 |
Merck Sharp & Dohme Corp. |
Novel low molecular weight cationic lipids for oligonucleotide delivery
|
CA2802360A1
(en)
|
2010-06-14 |
2011-12-22 |
Iowa State University Research Foundation, Inc. |
Nuclease activity of tal effector and foki fusion protein
|
US9549901B2
(en)
|
2010-09-03 |
2017-01-24 |
The Brigham And Women's Hospital, Inc. |
Lipid-polymer hybrid particles
|
ES2833075T3
(es)
|
2010-09-20 |
2021-06-14 |
Spi Pharma Inc |
Procedimiento de microencapsulación y producto
|
CA2814810A1
(en)
|
2010-10-20 |
2012-04-26 |
Dupont Nutrition Biosciences Aps |
Lactococcus crispr-cas sequences
|
CN103327970A
(zh)
|
2010-11-26 |
2013-09-25 |
约翰内斯堡威特沃特斯兰德大学 |
聚合物-脂质纳米粒子的聚合基质作为药物剂型
|
KR101255338B1
(ko)
|
2010-12-15 |
2013-04-16 |
포항공과대학교 산학협력단 |
표적 세포에 대한 폴리뉴클레오티드 전달체
|
CN103442698B
(zh)
|
2010-12-16 |
2016-10-05 |
细胞基因公司 |
难溶性药物的控释口服剂量形式及其用途
|
EP2663654A1
(en)
|
2011-01-14 |
2013-11-20 |
Life Technologies Corporation |
Methods, compositions, and kits for detecting rare cells
|
US9499592B2
(en)
|
2011-01-26 |
2016-11-22 |
President And Fellows Of Harvard College |
Transcription activator-like effectors
|
US9528124B2
(en)
|
2013-08-27 |
2016-12-27 |
Recombinetics, Inc. |
Efficient non-meiotic allele introgression
|
US9200045B2
(en)
|
2011-03-11 |
2015-12-01 |
President And Fellows Of Harvard College |
Small molecule-dependent inteins and uses thereof
|
US8709466B2
(en)
|
2011-03-31 |
2014-04-29 |
International Business Machines Corporation |
Cationic polymers for antimicrobial applications and delivery of bioactive materials
|
CA2832534C
(en)
|
2011-04-05 |
2022-01-04 |
Julien Valton |
Method for the generation of compact tale-nucleases and uses thereof
|
WO2012148953A1
(en)
|
2011-04-25 |
2012-11-01 |
Stc.Unm |
Solid compositions for pharmaceutical use
|
US8691750B2
(en)
|
2011-05-17 |
2014-04-08 |
Axolabs Gmbh |
Lipids and compositions for intracellular delivery of biologically active compounds
|
WO2012158986A2
(en)
|
2011-05-17 |
2012-11-22 |
Transposagen Biopharmaceuticals, Inc. |
Methods for site-specific genetic modification in stem cells using xanthomonas tal nucleases (xtn) for the creation of model organisms
|
WO2012158985A2
(en)
|
2011-05-17 |
2012-11-22 |
Transposagen Biopharmaceuticals, Inc. |
Methods for site-specific genetic modification in spermatogonial stem cells using zinc finger nuclease (zfn) for the creation of model organisms
|
WO2012164656A1
(ja)
|
2011-05-30 |
2012-12-06 |
トヨタ自動車株式会社 |
高強度ポリプロピレン繊維及びその製造方法
|
US20140113376A1
(en)
|
2011-06-01 |
2014-04-24 |
Rotem Sorek |
Compositions and methods for downregulating prokaryotic genes
|
DK2718437T3
(en)
|
2011-06-10 |
2018-08-06 |
Inst Nat Sante Rech Med |
Methods for the Treatment of Liver's Congenital Amaurosis
|
DK2543255T4
(da)
|
2011-07-04 |
2023-03-20 |
Dsm Ip Assets Bv |
Antilisteriel blandet kultur og fremgangsmåde til fremstilling af ost
|
JP6214530B2
(ja)
|
2011-07-15 |
2017-10-18 |
ザ ジェネラル ホスピタル コーポレイション |
転写活性化因子様エフェクターの組立て方法
|
US20140289882A1
(en)
|
2011-07-19 |
2014-09-25 |
Oregon Health And Science University |
Compositions and methods for re-programming cells without genetic modification for repairing cartilage damage
|
EP2734621B1
(en)
|
2011-07-22 |
2019-09-04 |
President and Fellows of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
EP2591770B1
(en)
|
2011-11-14 |
2016-03-16 |
Silenseed Ltd |
Compositions for siRNA delivery and methods of manufacturing and using same
|
US8450107B1
(en)
|
2011-11-30 |
2013-05-28 |
The Broad Institute Inc. |
Nucleotide-specific recognition sequences for designer TAL effectors
|
LT2791160T
(lt)
|
2011-12-16 |
2022-06-10 |
Modernatx, Inc. |
Modifikuotos mrnr sudėtys
|
GB201122458D0
(en)
|
2011-12-30 |
2012-02-08 |
Univ Wageningen |
Modified cascade ribonucleoproteins and uses thereof
|
SG10201606959PA
(en)
|
2012-02-24 |
2016-09-29 |
Hutchinson Fred Cancer Res |
Compositions and methods for the treatment of hemoglobinopathies
|
CN108285491B
(zh)
|
2012-02-29 |
2021-08-10 |
桑格摩生物科学股份有限公司 |
治疗亨廷顿氏病的方法和组合物
|
JP2015512255A
(ja)
|
2012-03-17 |
2015-04-27 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
ざ瘡の高速診断および個人化された治療
|
WO2013141680A1
(en)
|
2012-03-20 |
2013-09-26 |
Vilnius University |
RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
|
US9637739B2
(en)
|
2012-03-20 |
2017-05-02 |
Vilnius University |
RNA-directed DNA cleavage by the Cas9-crRNA complex
|
BR112014026203A2
(pt)
|
2012-04-23 |
2017-07-18 |
Bayer Cropscience Nv |
engenharia do genoma direcionado nas plantas
|
MX369788B
(es)
|
2012-05-02 |
2019-11-21 |
Dow Agrosciences Llc |
Modificacion dirigida de deshidrogenasa de malato.
|
BR112014027813A2
(pt)
|
2012-05-07 |
2017-08-08 |
Dow Agrosciences Llc |
métodos e composições para integração de transgenes direcionada mediada por nuclease
|
WO2013169398A2
(en)
|
2012-05-09 |
2013-11-14 |
Georgia Tech Research Corporation |
Systems and methods for improving nuclease specificity and activity
|
ES2728782T3
(es)
|
2012-05-25 |
2019-10-28 |
Univ California |
Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
|
EP3276000A3
(en)
|
2012-05-25 |
2018-02-21 |
Cellectis |
Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapy
|
US20150017136A1
(en)
|
2013-07-15 |
2015-01-15 |
Cellectis |
Methods for engineering allogeneic and highly active t cell for immunotherapy
|
IN2014DN10996A
(pt)
|
2012-05-30 |
2015-09-25 |
Baylor College Medicine |
|
US9102936B2
(en)
|
2012-06-11 |
2015-08-11 |
Agilent Technologies, Inc. |
Method of adaptor-dimer subtraction using a CRISPR CAS6 protein
|
CN104540382A
(zh)
|
2012-06-12 |
2015-04-22 |
弗·哈夫曼-拉罗切有限公司 |
用于产生条件性敲除等位基因的方法和组合物
|
EP2674501A1
(en)
|
2012-06-14 |
2013-12-18 |
Agence nationale de sécurité sanitaire de l'alimentation,de l'environnement et du travail |
Method for detecting and identifying enterohemorrhagic Escherichia coli
|
WO2013188638A2
(en)
|
2012-06-15 |
2013-12-19 |
The Regents Of The University Of California |
Endoribonucleases and methods of use thereof
|
BR112014031891A2
(pt)
|
2012-06-19 |
2017-08-01 |
Univ Minnesota |
direcionamento genético nas plantas utilizando vírus de dna
|
EP2867361B1
(en)
|
2012-06-29 |
2017-11-01 |
Massachusetts Institute of Technology |
Massively parallel combinatorial genetics
|
EP2872154B1
(en)
|
2012-07-11 |
2017-05-31 |
Sangamo BioSciences, Inc. |
Methods and compositions for delivery of biologics
|
DK3196301T3
(en)
|
2012-07-11 |
2019-01-14 |
Sangamo Therapeutics Inc |
METHODS AND COMPOSITIONS FOR TREATING MONOGENIC DISEASES
|
EP3494997B1
(en)
|
2012-07-25 |
2019-09-18 |
The Broad Institute, Inc. |
Inducible dna binding proteins and genome perturbation tools and applications thereof
|
US10058078B2
(en)
|
2012-07-31 |
2018-08-28 |
Recombinetics, Inc. |
Production of FMDV-resistant livestock by allele substitution
|
WO2014020608A1
(en)
|
2012-07-31 |
2014-02-06 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing and treating motor neuron diseases
|
EP2880171B1
(en)
|
2012-08-03 |
2018-10-03 |
The Regents of The University of California |
Methods and compositions for controlling gene expression by rna processing
|
LT2890780T
(lt)
|
2012-08-29 |
2020-11-10 |
Sangamo Therapeutics, Inc. |
Būdai ir kompozicijos, skirti genetinės būklės gydymui
|
WO2014039513A2
(en)
|
2012-09-04 |
2014-03-13 |
The Trustees Of The University Of Pennsylvania |
Inhibition of diacylglycerol kinase to augment adoptive t cell transfer
|
MX367730B
(es)
|
2012-09-04 |
2019-09-04 |
Cellectis |
Receptor de antigeno quimerico multi-cadena y usos del mismo.
|
TWI670004B
(zh)
|
2012-09-07 |
2019-09-01 |
美商陶氏農業科學公司 |
用來產生植物之螢光激活細胞分選富增技術
|
UA118090C2
(uk)
|
2012-09-07 |
2018-11-26 |
ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі |
Спосіб інтегрування послідовності нуклеїнової кислоти, що представляє інтерес, у ген fad2 у клітині сої та специфічний для локусу fad2 білок, що зв'язується, здатний індукувати спрямований розрив
|
RU2665811C2
(ru)
|
2012-09-07 |
2018-09-04 |
ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи |
Локусы fad3 для выполнения операций и соответствующие связывающиеся со специфическими сайтами-мишенями белки, способные к вызову направленных разрывов
|
UA119135C2
(uk)
|
2012-09-07 |
2019-05-10 |
ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі |
Спосіб отримання трансгенної рослини
|
WO2014043143A1
(en)
|
2012-09-11 |
2014-03-20 |
Life Technologies Corporation |
Nucleic acid amplification
|
GB201216564D0
(en)
|
2012-09-17 |
2012-10-31 |
Univ Edinburgh |
Genetically edited animal
|
WO2014047103A2
(en)
|
2012-09-18 |
2014-03-27 |
The Translational Genomics Research Institute |
Isolated genes and transgenic organisms for producing biofuels
|
EP3763810A3
(en)
|
2012-10-10 |
2021-07-14 |
Sangamo Therapeutics, Inc. |
T cell modifying compounds and uses thereof
|
EP2906602B1
(en)
|
2012-10-12 |
2019-01-16 |
The General Hospital Corporation |
Transcription activator-like effector (tale) - lysine-specific demethylase 1 (lsd1) fusion proteins
|
CN116064532A
(zh)
|
2012-10-23 |
2023-05-05 |
基因工具股份有限公司 |
用于切割靶dna的组合物及其用途
|
US20140115728A1
(en)
|
2012-10-24 |
2014-04-24 |
A. Joseph Tector |
Double knockout (gt/cmah-ko) pigs, organs and tissues
|
AP2015008495A0
(en)
|
2012-10-30 |
2015-05-31 |
Ct For Aquaculture Technologies Inc |
Control of sexual maturation in animals
|
US20150291967A1
(en)
|
2012-10-31 |
2015-10-15 |
Luc Mathis |
Coupling herbicide resistance with targeted insertion of transgenes in plants
|
US11041165B2
(en)
|
2012-10-31 |
2021-06-22 |
Two Blades Foundation |
Identification of a Xanthomonas euvesicatoria resistance gene from pepper (Capsicum annuum) and method for generating plants with resistance
|
US20150315576A1
(en)
|
2012-11-01 |
2015-11-05 |
Massachusetts Institute Of Technology |
Genetic device for the controlled destruction of dna
|
KR102121086B1
(ko)
|
2012-11-01 |
2020-06-09 |
팩터 바이오사이언스 인크. |
세포에서 단백질을 발현시키는 방법들과 생성물들
|
US20140127752A1
(en)
|
2012-11-07 |
2014-05-08 |
Zhaohui Zhou |
Method, composition, and reagent kit for targeted genomic enrichment
|
WO2014072941A1
(en)
|
2012-11-09 |
2014-05-15 |
Marco Archetti |
Diffusible factors and cancer cells
|
US9756871B2
(en)
|
2012-11-20 |
2017-09-12 |
J.R. Simplot Company |
TAL-mediated transfer DNA insertion
|
US20140140969A1
(en)
|
2012-11-20 |
2014-05-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for muscular dystrophies
|
WO2014081730A1
(en)
|
2012-11-20 |
2014-05-30 |
Cold Spring Harbor Laboratory |
Mutations in solanaceae plants that modulate shoot architecture and enhance yield-related phenotypes
|
DK3502240T3
(da)
|
2012-11-27 |
2021-08-09 |
Childrens Medical Ct Corp |
Målretning af distale bcl11a-reguleringselementer til føtal hæmoglobinreinduktion
|
US20140150135A1
(en)
|
2012-11-29 |
2014-05-29 |
North Carolina State University |
Synthetic Pathway for Biological Carbon Dioxide Sequestration
|
WO2014082644A1
(en)
|
2012-11-30 |
2014-06-05 |
WULFF, Peter, Samuel |
Circular rna for inhibition of microrna
|
US20160010154A1
(en)
|
2012-11-30 |
2016-01-14 |
The Parkinson's Institute |
Screening assays for therapeutics for parkinson's disease
|
WO2014089212A1
(en)
|
2012-12-05 |
2014-06-12 |
Sangamo Biosciences, Inc. |
Methods and compositions for regulation of metabolic disorders
|
KR102243092B1
(ko)
|
2012-12-06 |
2021-04-22 |
시그마-알드리치 컴퍼니., 엘엘씨 |
Crispr-기초된 유전체 변형과 조절
|
ES2682279T3
(es)
|
2012-12-06 |
2018-09-19 |
Synthetic Genomics, Inc. |
Mutantes de algas que tienen un fenotipo aclimatado a la luz intensa en compartimentos
|
WO2014089513A1
(en)
|
2012-12-06 |
2014-06-12 |
Synthetic Genomics, Inc. |
Autonomous replication sequences and episomal dna molecules
|
US9914931B2
(en)
|
2012-12-07 |
2018-03-13 |
Synthetic Genomics, Inc. |
Nannochloropsis spliced leader sequences and uses therefor
|
EP2928303A4
(en)
|
2012-12-07 |
2016-07-13 |
Haplomics Inc |
FACTOR VIII MUTATION REPAIR AND TOLERANCE INDUCTION
|
WO2014093479A1
(en)
|
2012-12-11 |
2014-06-19 |
Montana State University |
Crispr (clustered regularly interspaced short palindromic repeats) rna-guided control of gene regulation
|
EP2931899A1
(en)
|
2012-12-12 |
2015-10-21 |
The Broad Institute, Inc. |
Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
|
DK3327127T3
(da)
|
2012-12-12 |
2021-06-28 |
Broad Inst Inc |
Fremføring, modificering og optimering af systemer, fremgangsmåder og sammensætninger til sekvensmanipulation og terapeutiske anvendelser
|
AU2013359212B2
(en)
|
2012-12-12 |
2017-01-19 |
Massachusetts Institute Of Technology |
Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation
|
EP3064585B1
(en)
|
2012-12-12 |
2020-02-05 |
The Broad Institute, Inc. |
Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation
|
US8697359B1
(en)
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
EP4286404A3
(en)
|
2012-12-12 |
2024-02-14 |
The Broad Institute Inc. |
Crispr-cas component systems, methods and compositions for sequence manipulation
|
IL307735A
(en)
|
2012-12-12 |
2023-12-01 |
Broad Inst Inc |
Systems engineering, methods and optimal guiding components for sequence manipulation
|
EP2931892B1
(en)
|
2012-12-12 |
2018-09-12 |
The Broad Institute, Inc. |
Methods, models, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof
|
ES2576128T3
(es)
|
2012-12-12 |
2016-07-05 |
The Broad Institute, Inc. |
Modificación por tecnología genética y optimización de sistemas, métodos y composiciones para la manipulación de secuencias con dominios funcionales
|
US20140310830A1
(en)
|
2012-12-12 |
2014-10-16 |
Feng Zhang |
CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes
|
CN105144204B
(zh)
|
2012-12-13 |
2018-02-27 |
麻省理工学院 |
基于重组酶的逻辑与存储系统
|
AR093979A1
(es)
|
2012-12-13 |
2015-07-01 |
Dow Agrosciences Llc |
Metodos de deteccion de adn para actividad de nucleasa especifica de sitio
|
CA2895117A1
(en)
|
2012-12-13 |
2014-06-19 |
James W. Bing |
Precision gene targeting to a particular locus in maize
|
IL308158A
(en)
|
2012-12-17 |
2023-12-01 |
Harvard College |
RNA-guided human genome engineering
|
EP2934097B1
(en)
|
2012-12-21 |
2018-05-02 |
Cellectis |
Potatoes with reduced cold-induced sweetening
|
AU2014207618A1
(en)
|
2013-01-16 |
2015-08-06 |
Emory University |
Cas9-nucleic acid complexes and uses related thereto
|
CN103233028B
(zh)
|
2013-01-25 |
2015-05-13 |
南京徇齐生物技术有限公司 |
一种无物种限制无生物安全性问题的真核生物基因打靶方法及螺旋结构dna序列
|
US10660943B2
(en)
|
2013-02-07 |
2020-05-26 |
The Rockefeller University |
Sequence specific antimicrobials
|
WO2014127287A1
(en)
|
2013-02-14 |
2014-08-21 |
Massachusetts Institute Of Technology |
Method for in vivo tergated mutagenesis
|
US20150353885A1
(en)
|
2013-02-21 |
2015-12-10 |
Cellectis |
Method to counter-select cells or organisms by linking loci to nuclease components
|
ES2522765B2
(es)
|
2013-02-22 |
2015-03-18 |
Universidad De Alicante |
Método para dectectar inserciones de espaciadores en estructuras CRISPR
|
EP2958996B1
(en)
|
2013-02-25 |
2019-10-16 |
Sangamo Therapeutics, Inc. |
Methods and compositions for enhancing nuclease-mediated gene disruption
|
EP2922393B2
(en)
|
2013-02-27 |
2022-12-28 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Gene editing in the oocyte by cas9 nucleases
|
WO2014143381A1
(en)
|
2013-03-09 |
2014-09-18 |
Agilent Technologies, Inc. |
Methods of in vivo engineering of large sequences using multiple crispr/cas selections of recombineering events
|
WO2014164466A1
(en)
|
2013-03-12 |
2014-10-09 |
E. I. Du Pont De Nemours And Company |
Methods for the identification of variant recognition sites for rare-cutting engineered double-strand-break-inducing agents and compositions and uses thereof
|
EP2970886B1
(en)
|
2013-03-12 |
2018-05-23 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modification of hla
|
CN105980575A
(zh)
|
2013-03-14 |
2016-09-28 |
卡里布生物科学公司 |
以核酸为靶的核酸的组合物和方法
|
JP6980380B2
(ja)
|
2013-03-15 |
2021-12-15 |
ザ ジェネラル ホスピタル コーポレイション |
短縮ガイドRNA(tru−gRNA)を用いたRNA誘導型ゲノム編集の特異性の増大
|
US10760064B2
(en)
|
2013-03-15 |
2020-09-01 |
The General Hospital Corporation |
RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
|
US20140273230A1
(en)
|
2013-03-15 |
2014-09-18 |
Sigma-Aldrich Co., Llc |
Crispr-based genome modification and regulation
|
US9234213B2
(en)
|
2013-03-15 |
2016-01-12 |
System Biosciences, Llc |
Compositions and methods directed to CRISPR/Cas genomic engineering systems
|
AU2014227831B2
(en)
|
2013-03-15 |
2020-01-30 |
Regents Of The University Of Minnesota |
Engineering plant genomes using CRISPR/Cas systems
|
US11332719B2
(en)
|
2013-03-15 |
2022-05-17 |
The Broad Institute, Inc. |
Recombinant virus and preparations thereof
|
WO2014144094A1
(en)
|
2013-03-15 |
2014-09-18 |
J.R. Simplot Company |
Tal-mediated transfer dna insertion
|
US20140349400A1
(en)
|
2013-03-15 |
2014-11-27 |
Massachusetts Institute Of Technology |
Programmable Modification of DNA
|
JP6346266B2
(ja)
|
2013-03-21 |
2018-06-20 |
サンガモ セラピューティクス, インコーポレイテッド |
操作されたジンクフィンガータンパク質ヌクレアーゼを使用するt細胞受容体遺伝子の標的化された破壊
|
US11274305B2
(en)
|
2013-04-04 |
2022-03-15 |
Trustees Of Dartmouth College |
Compositions and methods for in vivo excision of HIV-1 proviral DNA
|
WO2014165825A2
(en)
|
2013-04-04 |
2014-10-09 |
President And Fellows Of Harvard College |
Therapeutic uses of genome editing with crispr/cas systems
|
EP3679785A3
(en)
|
2013-04-05 |
2020-09-16 |
Dow AgroSciences LLC |
Methods and compositions for integration of an exogenous sequence within the genome of plants
|
US20150056629A1
(en)
|
2013-04-14 |
2015-02-26 |
Katriona Guthrie-Honea |
Compositions, systems, and methods for detecting a DNA sequence
|
US20160186208A1
(en)
|
2013-04-16 |
2016-06-30 |
Whitehead Institute For Biomedical Research |
Methods of Mutating, Modifying or Modulating Nucleic Acid in a Cell or Nonhuman Mammal
|
EP2986709A4
(en)
|
2013-04-16 |
2017-03-15 |
University Of Washington Through Its Center For Commercialization |
Activating an alternative pathway for homology-directed repair to stimulate targeted gene correction and genome engineering
|
PL3456831T3
(pl)
|
2013-04-16 |
2021-12-06 |
Regeneron Pharmaceuticals, Inc. |
Ukierunkowana modyfikacja genomu szczura
|
CN103224947B
(zh)
|
2013-04-28 |
2015-06-10 |
陕西师范大学 |
一种基因打靶系统
|
JP2016518142A
(ja)
|
2013-05-10 |
2016-06-23 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
ヌクレアーゼ媒介ゲノム遺伝子操作のための送達方法および組成物
|
ES2901383T3
(es)
|
2013-05-10 |
2022-03-22 |
Whitehead Inst Biomedical Res |
Producción in vitro de glóbulos rojos con proteínas marcables con sortasa
|
WO2014184744A1
(en)
|
2013-05-13 |
2014-11-20 |
Cellectis |
Methods for engineering highly active t cell for immunotherapy
|
EP2997141B1
(en)
|
2013-05-13 |
2022-10-12 |
Cellectis |
Cd19 specific chimeric antigen receptor and uses thereof
|
CN105683376A
(zh)
|
2013-05-15 |
2016-06-15 |
桑格摩生物科学股份有限公司 |
用于治疗遗传病状的方法和组合物
|
WO2014186686A2
(en)
|
2013-05-17 |
2014-11-20 |
Two Blades Foundation |
Targeted mutagenesis and genome engineering in plants using rna-guided cas nucleases
|
CA2913234A1
(en)
|
2013-05-22 |
2014-11-27 |
Northwestern University |
Rna-directed dna cleavage and gene editing by cas9 enzyme from neisseria meningitidis
|
US11414695B2
(en)
|
2013-05-29 |
2022-08-16 |
Agilent Technologies, Inc. |
Nucleic acid enrichment using Cas9
|
JP7065564B2
(ja)
|
2013-05-29 |
2022-05-12 |
セレクティス |
Cas9ニッカーゼ活性を用いて正確なdna切断をもたらすための方法
|
ES2883131T3
(es)
|
2013-05-29 |
2021-12-07 |
Cellectis |
Métodos para la modificación de células T para inmunoterapia utilizando el sistema de nucleasa CAS guiado por ARN
|
AU2014273085B2
(en)
|
2013-05-29 |
2020-10-22 |
Cellectis |
New compact scaffold of Cas9 in the type II CRISPR system
|
ES2645393T3
(es)
|
2013-05-29 |
2017-12-05 |
Cellectis |
Métodos de manipulación de linfocitos T para inmunoterapia usando el sistema de nucleasa Cas guiada por ARN
|
US20150067922A1
(en)
*
|
2013-05-30 |
2015-03-05 |
The Penn State Research Foundation |
Gene targeting and genetic modification of plants via rna-guided genome editing
|
CA2913871C
(en)
|
2013-05-31 |
2021-07-13 |
Cellectis |
A laglidadg homing endonuclease cleaving the c-c chemokine receptor type-5 (ccr5) gene and uses thereof
|
US10000746B2
(en)
|
2013-05-31 |
2018-06-19 |
Cellectis |
LAGLIDADG homing endonuclease cleaving the T cell receptor alpha gene and uses thereof
|
US20140359795A1
(en)
|
2013-05-31 |
2014-12-04 |
Recombinetics, Inc. |
Genetic techniques for making animals with sortable sperm
|
US9267135B2
(en)
|
2013-06-04 |
2016-02-23 |
President And Fellows Of Harvard College |
RNA-guided transcriptional regulation
|
MX2015016798A
(es)
|
2013-06-04 |
2016-10-26 |
Harvard College |
Regulacion transcripcional guiada por acido ribonucleico.
|
AU2014274840B2
(en)
|
2013-06-05 |
2020-03-12 |
Duke University |
RNA-guided gene editing and gene regulation
|
EP3008181B1
(en)
|
2013-06-11 |
2019-11-06 |
The Regents of The University of California |
Methods and compositions for target dna modification
|
US9593356B2
(en)
|
2013-06-11 |
2017-03-14 |
Takara Bio Usa, Inc. |
Protein enriched microvesicles and methods of making and using the same
|
CA2915834A1
(en)
|
2013-06-17 |
2014-12-24 |
Massachusetts Institute Of Technology |
Delivery, engineering and optimization of tandem guide systems, methods and compositions for sequence manipulation
|
EP3011033B1
(en)
|
2013-06-17 |
2020-02-19 |
The Broad Institute, Inc. |
Functional genomics using crispr-cas systems, compositions methods, screens and applications thereof
|
BR112015031611A2
(pt)
|
2013-06-17 |
2017-12-12 |
Massachusetts Inst Technology |
aplicação, manipulação e otimização de sistemas, métodos e composições para direcionamento e modelação de doenças e distúrbios de células pós-mitóticas
|
EP4245853A3
(en)
|
2013-06-17 |
2023-10-18 |
The Broad Institute, Inc. |
Optimized crispr-cas double nickase systems, methods and compositions for sequence manipulation
|
DK3011031T3
(da)
|
2013-06-17 |
2020-12-21 |
Broad Inst Inc |
Fremføring og anvendelse af crispr-cas-systemerne, vektorer og sammensætninger til levermålretning og -terapi
|
WO2014204723A1
(en)
|
2013-06-17 |
2014-12-24 |
The Broad Institute Inc. |
Oncogenic models based on delivery and use of the crispr-cas systems, vectors and compositions
|
WO2014204729A1
(en)
|
2013-06-17 |
2014-12-24 |
The Broad Institute Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using viral components
|
US10011850B2
(en)
|
2013-06-21 |
2018-07-03 |
The General Hospital Corporation |
Using RNA-guided FokI Nucleases (RFNs) to increase specificity for RNA-Guided Genome Editing
|
US20160369268A1
(en)
|
2013-07-01 |
2016-12-22 |
The Board Of Regents Of The University Of Texas System |
Transcription activator-like effector (tale) libraries and methods of synthesis and use
|
CN103343120B
(zh)
|
2013-07-04 |
2015-03-04 |
中国科学院遗传与发育生物学研究所 |
一种小麦基因组定点改造方法
|
KR20230122182A
(ko)
|
2013-07-09 |
2023-08-22 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
멀티플렉스 rna-가이드된 게놈 조작
|
JP2016528890A
(ja)
|
2013-07-09 |
2016-09-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
CRISPR/Cas系を用いるゲノム編集の治療用の使用
|
EP3666892A1
(en)
|
2013-07-10 |
2020-06-17 |
President and Fellows of Harvard College |
Orthogonal cas9 proteins for rna-guided gene regulation and editing
|
AU2014289183A1
(en)
|
2013-07-10 |
2016-01-21 |
Glykos Finland Oy |
Multiple proteases deficient filamentous fungal cells and methods of use thereof
|
DK3019619T3
(da)
|
2013-07-11 |
2021-10-11 |
Modernatx Inc |
Sammensætninger, der omfatter syntetiske polynukleotider, som koder for crispr-beslægtede proteiner, og syntetiske sgrna'er, og anvendelsesfremgangsmåder
|
JP6482546B2
(ja)
|
2013-07-19 |
2019-03-13 |
ラリクス・バイオサイエンス・リミテッド・ライアビリティ・カンパニーLarix Bioscience, Llc |
二重対立遺伝子ノックアウトを生成するための方法および組成物
|
CN103388006B
(zh)
|
2013-07-26 |
2015-10-28 |
华东师范大学 |
一种基因定点突变的构建方法
|
US10563225B2
(en)
|
2013-07-26 |
2020-02-18 |
President And Fellows Of Harvard College |
Genome engineering
|
US10421957B2
(en)
|
2013-07-29 |
2019-09-24 |
Agilent Technologies, Inc. |
DNA assembly using an RNA-programmable nickase
|
EP3027754B1
(en)
|
2013-08-02 |
2022-03-02 |
enEvolv, Inc. |
Processes and host cells for genome, pathway, and biomolecular engineering
|
ITTO20130669A1
(it)
|
2013-08-05 |
2015-02-06 |
Consiglio Nazionale Ricerche |
Vettore adeno-associato ricombinante muscolo-specifico e suo impiego nel trattamento di patologie muscolari
|
US20150044772A1
(en)
|
2013-08-09 |
2015-02-12 |
Sage Labs, Inc. |
Crispr/cas system-based novel fusion protein and its applications in genome editing
|
US9163284B2
(en)
|
2013-08-09 |
2015-10-20 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a Cas9 nuclease
|
WO2015021990A1
(en)
|
2013-08-16 |
2015-02-19 |
University Of Copenhagen |
Rna probing method and reagents
|
WO2015024017A2
(en)
|
2013-08-16 |
2015-02-19 |
President And Fellows Of Harvard College |
Rna polymerase, methods of purification and methods of use
|
ES2729635T3
(es)
|
2013-08-22 |
2019-11-05 |
Pioneer Hi Bred Int |
Modificación genómica usando sistemas de polinucleótido guía/endonucleasa Cas y métodos de uso
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
EP3988654A1
(en)
|
2013-08-28 |
2022-04-27 |
Sangamo Therapeutics, Inc. |
Compositions for linking dna-binding domains and cleavage domains
|
CN106102781A
(zh)
|
2013-08-29 |
2016-11-09 |
英联邦高等教育系统天普大学 |
用于hiv感染的rna指导的治疗的方法和组合物
|
EP3041931B1
(en)
|
2013-09-04 |
2020-06-10 |
Csir |
Site-specific nuclease single-cell assay targeting gene regulatory elements to silence gene expression
|
EP4074330A1
(en)
|
2013-09-05 |
2022-10-19 |
Massachusetts Institute of Technology |
Tuning microbial populations with programmable nucleases
|
US9340800B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
Extended DNA-sensing GRNAS
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
US9737604B2
(en)
|
2013-09-06 |
2017-08-22 |
President And Fellows Of Harvard College |
Use of cationic lipids to deliver CAS9
|
WO2015040075A1
(en)
|
2013-09-18 |
2015-03-26 |
Genome Research Limited |
Genomic screening methods using rna-guided endonucleases
|
DE202014010413U1
(de)
|
2013-09-18 |
2015-12-08 |
Kymab Limited |
Zellen und Organismen
|
US20160237455A1
(en)
|
2013-09-27 |
2016-08-18 |
Editas Medicine, Inc. |
Crispr-related methods and compositions
|
WO2015048690A1
(en)
|
2013-09-27 |
2015-04-02 |
The Regents Of The University Of California |
Optimized small guide rnas and methods of use
|
US20150098954A1
(en)
|
2013-10-08 |
2015-04-09 |
Elwha Llc |
Compositions and Methods Related to CRISPR Targeting
|
DE102013111099B4
(de)
|
2013-10-08 |
2023-11-30 |
Eberhard Karls Universität Tübingen Medizinische Fakultät |
Permanente Genkorrektur mittels nukleotidmodifizierter messenger RNA
|
WO2015052231A2
(en)
|
2013-10-08 |
2015-04-16 |
Technical University Of Denmark |
Multiplex editing system
|
WO2015057980A1
(en)
|
2013-10-17 |
2015-04-23 |
Sangamo Biosciences, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
EP3057432B1
(en)
|
2013-10-17 |
2018-11-21 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells
|
US10508289B2
(en)
|
2013-10-25 |
2019-12-17 |
Cellectis |
Rare-cutting endonucleases for efficient and specific targeting DNA sequences comprising highly repetitive motives
|
WO2015065964A1
(en)
|
2013-10-28 |
2015-05-07 |
The Broad Institute Inc. |
Functional genomics using crispr-cas systems, compositions, methods, screens and applications thereof
|
WO2015066119A1
(en)
|
2013-10-30 |
2015-05-07 |
North Carolina State University |
Compositions and methods related to a type-ii crispr-cas system in lactobacillus buchneri
|
AU2014341928B2
(en)
|
2013-11-04 |
2017-11-30 |
Corteva Agriscience Llc |
A universal donor system for gene targeting
|
PT3066201T
(pt)
|
2013-11-07 |
2018-06-04 |
Massachusetts Inst Technology |
Métodos e composições relacionadas com crispr com arng reguladores
|
KR102431079B1
(ko)
|
2013-11-11 |
2022-08-11 |
상가모 테라퓨틱스, 인코포레이티드 |
헌팅턴병을 치료하기 위한 방법 및 조성물
|
WO2015073683A2
(en)
|
2013-11-13 |
2015-05-21 |
Children's Medical Center Corporation |
Nuclease-mediated regulation of gene expression
|
US9951353B2
(en)
|
2013-11-15 |
2018-04-24 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Engineering neural stem cells using homologous recombination
|
KR20160091920A
(ko)
|
2013-11-18 |
2016-08-03 |
예일 유니버시티 |
트랜스포존 조성물 및 이의 이용 방법
|
CA2930877A1
(en)
|
2013-11-18 |
2015-05-21 |
Crispr Therapeutics Ag |
Crispr-cas system materials and methods
|
US10787684B2
(en)
|
2013-11-19 |
2020-09-29 |
President And Fellows Of Harvard College |
Large gene excision and insertion
|
WO2015075056A1
(en)
|
2013-11-19 |
2015-05-28 |
Thermo Fisher Scientific Baltics Uab |
Programmable enzymes for isolation of specific dna fragments
|
US9074199B1
(en)
|
2013-11-19 |
2015-07-07 |
President And Fellows Of Harvard College |
Mutant Cas9 proteins
|
WO2015075154A2
(en)
|
2013-11-20 |
2015-05-28 |
Fondazione Telethon |
Artificial dna-binding proteins and uses thereof
|
EP3071687B1
(en)
|
2013-11-22 |
2019-07-31 |
Cellectis |
Method of engineering chemotherapy drug resistant t-cells for immunotherapy
|
CN103642836A
(zh)
|
2013-11-26 |
2014-03-19 |
苏州同善生物科技有限公司 |
一种基于crispr基因敲除技术建立脆性x综合症灵长类动物模型的方法
|
CN103614415A
(zh)
|
2013-11-27 |
2014-03-05 |
苏州同善生物科技有限公司 |
一种基于crispr基因敲除技术建立肥胖症大鼠动物模型的方法
|
US10557151B2
(en)
|
2013-11-28 |
2020-02-11 |
Horizon Discovery Limited |
Somatic human cell line mutations
|
AU2014363991B2
(en)
|
2013-12-09 |
2020-08-27 |
Sangamo Therapeutics, Inc. |
Methods and compositions for genome engineering
|
RU2685914C1
(ru)
|
2013-12-11 |
2019-04-23 |
Регенерон Фармасьютикалс, Инк. |
Способы и композиции для направленной модификации генома
|
WO2015089351A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Compositions and methods of use of crispr-cas systems in nucleotide repeat disorders
|
US9994831B2
(en)
|
2013-12-12 |
2018-06-12 |
The Regents Of The University Of California |
Methods and compositions for modifying a single stranded target nucleic acid
|
US20150165054A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting caspase-9 point mutations
|
EP3080260B1
(en)
|
2013-12-12 |
2019-03-06 |
The Broad Institute, Inc. |
Crispr-cas systems and methods for altering expression of gene products, structural information and inducible modular cas enzymes
|
WO2015089473A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation
|
WO2015089364A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Crystal structure of a crispr-cas system, and uses thereof
|
AU2014361781B2
(en)
|
2013-12-12 |
2021-04-01 |
Massachusetts Institute Of Technology |
Delivery, use and therapeutic applications of the CRISPR -Cas systems and compositions for genome editing
|
KR20160089530A
(ko)
|
2013-12-12 |
2016-07-27 |
더 브로드 인스티튜트, 인코퍼레이티드 |
Hbv 및 바이러스 질병 및 질환을 위한 crisprcas 시스템 및 조성물의 전달,용도 및 치료적 적용
|
WO2015089419A2
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using particle delivery components
|
WO2015089486A2
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Systems, methods and compositions for sequence manipulation with optimized functional crispr-cas systems
|
US20160304893A1
(en)
|
2013-12-13 |
2016-10-20 |
Cellectis |
Cas9 nuclease platform for microalgae genome engineering
|
CA2932948A1
(en)
|
2013-12-13 |
2015-06-18 |
Cellectis |
New method of selection of algal-transformed cells using nuclease
|
US20150191744A1
(en)
|
2013-12-17 |
2015-07-09 |
University Of Massachusetts |
Cas9 effector-mediated regulation of transcription, differentiation and gene editing/labeling
|
JP6652489B2
(ja)
|
2013-12-19 |
2020-02-26 |
アミリス, インコーポレイテッド |
ゲノム組込みのための方法
|
KR20160102056A
(ko)
|
2013-12-26 |
2016-08-26 |
더 제너럴 하스피탈 코포레이션 |
멀티플렉스 가이드 rna
|
CN103668472B
(zh)
|
2013-12-31 |
2014-12-24 |
北京大学 |
利用CRISPR/Cas9系统构建真核基因敲除文库的方法
|
EP3089989B1
(en)
|
2013-12-31 |
2020-06-24 |
The Regents of The University of California |
Cas9 crystals and methods of use thereof
|
SG11201605550QA
(en)
|
2014-01-08 |
2016-08-30 |
Harvard College |
Rna-guided gene drives
|
WO2015108993A1
(en)
|
2014-01-14 |
2015-07-23 |
Lam Therapeutics, Inc. |
Mutagenesis methods
|
US10774338B2
(en)
|
2014-01-16 |
2020-09-15 |
The Regents Of The University Of California |
Generation of heritable chimeric plant traits
|
US10034463B2
(en)
|
2014-01-24 |
2018-07-31 |
Children's Medical Center Corporation |
High-throughput mouse model for optimizing antibody affinities
|
EP3097212A4
(en)
|
2014-01-24 |
2017-10-04 |
North Carolina State University |
Methods and compositions for sequences guiding cas9 targeting
|
US10354746B2
(en)
|
2014-01-27 |
2019-07-16 |
Georgia Tech Research Corporation |
Methods and systems for identifying CRISPR/Cas off-target sites
|
CN104805078A
(zh)
|
2014-01-28 |
2015-07-29 |
北京大学 |
用于高效基因组编辑的rna分子的设计、合成及其应用
|
WO2015116686A1
(en)
|
2014-01-29 |
2015-08-06 |
Agilent Technologies, Inc. |
Cas9-based isothermal method of detection of specific dna sequence
|
US20150291969A1
(en)
|
2014-01-30 |
2015-10-15 |
Chromatin, Inc. |
Compositions for reduced lignin content in sorghum and improving cell wall digestibility, and methods of making the same
|
WO2015115903A1
(en)
|
2014-02-03 |
2015-08-06 |
Academisch Ziekenhuis Leiden H.O.D.N. Lumc |
Site-specific dna break-induced genome editing using engineered nucleases
|
CN111705365A
(zh)
|
2014-02-11 |
2020-09-25 |
科罗拉多州立大学董事会(法人团体) |
Crispr支持的多路基因组工程化
|
US10150985B2
(en)
|
2014-02-13 |
2018-12-11 |
Takara Bio Usa, Inc. |
Methods of depleting a target molecule from an initial collection of nucleic acids, and compositions and kits for practicing the same
|
CN106029875A
(zh)
|
2014-02-14 |
2016-10-12 |
塞勒克提斯公司 |
为了靶向存在于免疫细胞和病理细胞两者上的抗原而工程化的免疫治疗细胞
|
SG11201606819QA
(en)
|
2014-02-18 |
2016-09-29 |
Univ Duke |
Compositions for the inactivation of virus replication and methods of making and using the same
|
AU2015218576B2
(en)
|
2014-02-24 |
2020-02-27 |
Sangamo Therapeutics, Inc. |
Methods and compositions for nuclease-mediated targeted integration
|
US20170015994A1
(en)
|
2014-02-24 |
2017-01-19 |
Massachusetts Institute Of Technology |
Methods for in vivo genome editing
|
CA2940217C
(en)
|
2014-02-27 |
2023-06-13 |
Monsanto Technology Llc |
Compositions and methods for site directed genomic modification
|
CN103820441B
(zh)
|
2014-03-04 |
2017-05-17 |
黄行许 |
CRISPR‑Cas9特异性敲除人CTLA4基因的方法以及用于特异性靶向CTLA4基因的sgRNA
|
CN103820454B
(zh)
|
2014-03-04 |
2016-03-30 |
上海金卫生物技术有限公司 |
CRISPR-Cas9特异性敲除人PD1基因的方法以及用于特异性靶向PD1基因的sgRNA
|
US11028388B2
(en)
|
2014-03-05 |
2021-06-08 |
Editas Medicine, Inc. |
CRISPR/Cas-related methods and compositions for treating Usher syndrome and retinitis pigmentosa
|
ES2745769T3
(es)
|
2014-03-10 |
2020-03-03 |
Editas Medicine Inc |
Procedimientos y composiciones relacionados con CRISPR/CAS para tratar la amaurosis congénita de Leber 10 (LCA10)
|
EP3116902B1
(en)
|
2014-03-11 |
2020-01-01 |
Cellectis |
Method for generating t-cells compatible for allogenic transplantation
|
US20170106055A1
(en)
|
2014-03-12 |
2017-04-20 |
Precision Biosciences, Inc. |
Dystrophin Gene Exon Deletion Using Engineered Nucleases
|
WO2015138870A2
(en)
|
2014-03-13 |
2015-09-17 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for targeted epigenetic modification
|
WO2015138855A1
(en)
|
2014-03-14 |
2015-09-17 |
The Regents Of The University Of California |
Vectors and methods for fungal genome engineering by crispr-cas9
|
RS65213B1
(sr)
|
2014-03-14 |
2024-03-29 |
Cibus Us Llc |
Postupci i kompozicije za povećanje efikasnosti ciljane modifikacije gena korišćenjem reparacije gena posredovane oligonukleotidima
|
WO2015143046A2
(en)
|
2014-03-18 |
2015-09-24 |
Sangamo Biosciences, Inc. |
Methods and compositions for regulation of zinc finger protein expression
|
JP2017514513A
(ja)
|
2014-03-20 |
2017-06-08 |
ユニベルシテ ラバル |
フラタキシンレベルを増加させるためのcrispr系の方法及び生成物、ならびにそれらの使用
|
EP3129484A1
(en)
|
2014-03-25 |
2017-02-15 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating hiv infection and aids
|
AU2015236045B2
(en)
|
2014-03-25 |
2021-09-23 |
Ginkgo Bioworks, Inc. |
Methods and genetic systems for cell engineering
|
JP6815986B2
(ja)
|
2014-03-26 |
2021-01-20 |
ユニバーシティ オブ メリーランド, カレッジ パーク |
大型家畜の接合体における標的化ゲノム編集
|
US11242525B2
(en)
|
2014-03-26 |
2022-02-08 |
Editas Medicine, Inc. |
CRISPR/CAS-related methods and compositions for treating sickle cell disease
|
WO2015148860A1
(en)
|
2014-03-26 |
2015-10-01 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating beta-thalassemia
|
WO2015153760A2
(en)
|
2014-04-01 |
2015-10-08 |
Sangamo Biosciences, Inc. |
Methods and compositions for prevention or treatment of a nervous system disorder
|
WO2015153791A1
(en)
|
2014-04-01 |
2015-10-08 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating herpes simplex virus type 2 (hsv-2)
|
WO2015153789A1
(en)
|
2014-04-01 |
2015-10-08 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating herpes simplex virus type 1 (hsv-1)
|
US20170029850A1
(en)
|
2014-04-02 |
2017-02-02 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating primary open angle glaucoma
|
CN103911376B
(zh)
|
2014-04-03 |
2017-02-15 |
黄行许 |
CRISPR‑Cas9靶向敲除乙肝病毒cccDNA及其特异性sgRNA
|
US20170022499A1
(en)
|
2014-04-03 |
2017-01-26 |
Massachusetts Institute Of Techology |
Methods and compositions for the production of guide rna
|
CN106460003A
(zh)
|
2014-04-08 |
2017-02-22 |
北卡罗来纳州立大学 |
用于使用crispr相关基因rna引导阻遏转录的方法和组合物
|
EP3556858A3
(en)
|
2014-04-09 |
2020-01-22 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating cystic fibrosis
|
WO2015157534A1
(en)
|
2014-04-10 |
2015-10-15 |
The Regents Of The University Of California |
Methods and compositions for using argonaute to modify a single stranded target nucleic acid
|
WO2015155341A1
(en)
|
2014-04-11 |
2015-10-15 |
Cellectis |
Method for generating immune cells resistant to arginine and/or tryptophan depleted microenvironment
|
SG11201608503UA
(en)
|
2014-04-14 |
2016-11-29 |
Maxcyte Inc |
Methods and compositions for modifying genomic dna
|
CN103923911B
(zh)
|
2014-04-14 |
2016-06-08 |
上海金卫生物技术有限公司 |
CRISPR-Cas9特异性敲除人CCR5基因的方法以及用于特异性靶向CCR5基因的sgRNA
|
AU2015248621B2
(en)
|
2014-04-14 |
2020-08-27 |
Nemesis Bioscience Ltd |
Therapeutic
|
GB201406968D0
(en)
|
2014-04-17 |
2014-06-04 |
Green Biologics Ltd |
Deletion mutants
|
GB201406970D0
(en)
|
2014-04-17 |
2014-06-04 |
Green Biologics Ltd |
Targeted mutations
|
KR102595473B1
(ko)
|
2014-04-18 |
2023-10-30 |
에디타스 메디신, 인코포레이티드 |
암 면역요법을 위한 crispr-cas-관련 방법, 조성물 및 구성성분
|
CN104004778B
(zh)
|
2014-06-06 |
2016-03-02 |
重庆高圣生物医药有限责任公司 |
含有CRISPR/Cas9系统的靶向敲除载体及其腺病毒和应用
|
CN104109687A
(zh)
|
2014-07-14 |
2014-10-22 |
四川大学 |
运动发酵单胞菌CRISPR-Cas9系统的构建与应用
|
CN104178461B
(zh)
|
2014-08-14 |
2017-02-01 |
北京蛋白质组研究中心 |
携带cas9的重组腺病毒及其应用
|
EP3686279B1
(en)
|
2014-08-17 |
2023-01-04 |
The Broad Institute, Inc. |
Genome editing using cas9 nickases
|
CN104342457A
(zh)
|
2014-10-17 |
2015-02-11 |
杭州师范大学 |
一种将外源基因定点整合到靶标基因的方法
|
CN104404036B
(zh)
|
2014-11-03 |
2017-12-01 |
赛业(苏州)生物科技有限公司 |
基于CRISPR/Cas9技术的条件性基因敲除方法
|
CN104504304B
(zh)
|
2014-11-03 |
2017-08-25 |
深圳先进技术研究院 |
一种成簇的规律间隔的短回文重复序列识别方法及装置
|
PL3221457T3
(pl)
|
2014-11-21 |
2019-09-30 |
Regeneron Pharmaceuticals, Inc. |
Sposoby i kompozycje do celowanej modyfikacji genetycznej z zastosowaniem sparowanych przewodników RNA
|
CN104450774A
(zh)
|
2014-12-04 |
2015-03-25 |
中国农业科学院作物科学研究所 |
一种大豆CRISPR/Cas9体系的构建及其在大豆基因修饰中的应用
|
CN104531704B
(zh)
|
2014-12-09 |
2019-05-21 |
中国农业大学 |
利用CRISPR-Cas9系统敲除动物FGF5基因的方法
|
CN104531705A
(zh)
|
2014-12-09 |
2015-04-22 |
中国农业大学 |
利用CRISPR-Cas9系统敲除动物myostatin基因的方法
|
CN104480144B
(zh)
|
2014-12-12 |
2017-04-12 |
武汉大学 |
用于艾滋病基因治疗的CRISPR/Cas9重组慢病毒载体及其慢病毒
|
CN104745626B
(zh)
|
2014-12-19 |
2018-05-01 |
中国航天员科研训练中心 |
一种条件性基因敲除动物模型的快速构建方法及应用
|
CN104560864B
(zh)
|
2014-12-22 |
2017-08-11 |
中国科学院微生物研究所 |
利用CRISPR‑Cas9系统构建的敲除IFN‑β基因的293T细胞系
|
WO2016106236A1
(en)
|
2014-12-23 |
2016-06-30 |
The Broad Institute Inc. |
Rna-targeting system
|
CN104651398A
(zh)
|
2014-12-24 |
2015-05-27 |
杭州师范大学 |
利用CRISPR-Cas9特异敲出microRNA基因家族的方法
|
CN104498493B
(zh)
|
2014-12-30 |
2017-12-26 |
武汉大学 |
CRISPR/Cas9特异性敲除乙型肝炎病毒的方法以及用于特异性靶向HBV DNA的gRNA
|
CN104651399B
(zh)
|
2014-12-31 |
2018-11-16 |
广西大学 |
一种利用CRISPR/Cas系统在猪胚胎细胞中实现基因敲除的方法
|
CN104651392B
(zh)
|
2015-01-06 |
2018-07-31 |
华南农业大学 |
一种利用CRISPR/Cas9系统定点突变P/TMS12-1获得温敏不育系的方法
|
CN104593422A
(zh)
|
2015-01-08 |
2015-05-06 |
中国农业大学 |
一种抗蓝耳病克隆猪的制备方法
|
CN104611370A
(zh)
|
2015-01-16 |
2015-05-13 |
深圳市科晖瑞生物医药有限公司 |
一种剔除β2-微球蛋白基因片段的方法
|
CN104725626B
(zh)
|
2015-01-22 |
2016-06-29 |
漳州亚邦化学有限公司 |
一种适用于人造石英石的不饱和树脂的制备方法
|
CN104593418A
(zh)
|
2015-02-06 |
2015-05-06 |
中国医学科学院医学实验动物研究所 |
一种人源化大鼠药物评价动物模型建立的方法
|
CN104928321B
(zh)
|
2015-02-12 |
2018-06-01 |
中国科学院西北高原生物研究所 |
一种由Crispr/Cas9诱导的鳞片缺失斑马鱼模式及建立方法
|
CN104726494B
(zh)
|
2015-02-12 |
2018-10-23 |
中国人民解放军第二军医大学 |
CRISPR-Cas9技术构建染色体易位干细胞及动物模型的方法
|
CN104805099B
(zh)
|
2015-03-02 |
2018-04-13 |
中国人民解放军第二军医大学 |
一种安全编码Cas9蛋白的核酸分子及其表达载体
|
CN104673816A
(zh)
|
2015-03-05 |
2015-06-03 |
广东医学院 |
一种pCr-NHEJ载体及其构建方法及其用于细菌基因定点敲除的应用
|
CN104651401B
(zh)
|
2015-03-05 |
2019-03-08 |
东华大学 |
一种mir-505双等位基因敲除的方法
|
CN104726449A
(zh)
|
2015-03-23 |
2015-06-24 |
国家纳米科学中心 |
一种用于预防和/或治疗HIV的CRISPR-Cas9系统及其制备方法和用途
|
GB201506509D0
(en)
|
2015-04-16 |
2015-06-03 |
Univ Wageningen |
Nuclease-mediated genome editing
|
CN104805118A
(zh)
|
2015-04-22 |
2015-07-29 |
扬州大学 |
一种苏禽黄鸡胚胎干细胞特定基因进行靶向敲除方法
|
CN104762321A
(zh)
|
2015-04-22 |
2015-07-08 |
东北林业大学 |
基于CRISPR/Cas9系统靶向敲除KHV基因的敲除载体构建方法及其crRNA原件
|
CN104894068A
(zh)
|
2015-05-04 |
2015-09-09 |
南京凯地生物科技有限公司 |
一种利用CRISPR/Cas9制备CAR-T细胞的方法
|
CN104846010B
(zh)
|
2015-05-18 |
2018-07-06 |
安徽省农业科学院水稻研究所 |
一种删除转基因水稻筛选标记基因的方法
|
CN104894075B
(zh)
|
2015-05-28 |
2019-08-06 |
华中农业大学 |
CRISPR/Cas9和Cre/lox系统编辑伪狂犬病毒基因组制备疫苗方法和应用
|
WO2016205759A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
|
EP3436575A1
(en)
|
2015-06-18 |
2019-02-06 |
The Broad Institute Inc. |
Novel crispr enzymes and systems
|
US9790490B2
(en)
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
US20190048340A1
(en)
|
2015-09-24 |
2019-02-14 |
Crispr Therapeutics Ag |
Novel family of rna-programmable endonucleases and their uses in genome editing and other applications
|
EP3362104A4
(en)
|
2015-10-16 |
2019-03-27 |
Temple University - Of The Commonwealth System of Higher Education |
METHODS AND COMPOSITIONS USING CPF1 FOR RNA-GUIDED GENETIC EDITION
|
EP3365441A1
(en)
|
2015-10-22 |
2018-08-29 |
The Broad Institute Inc. |
Type vi-b crispr enzymes and systems
|
WO2017099494A1
(ko)
|
2015-12-08 |
2017-06-15 |
기초과학연구원 |
Cpf1을 포함하는 유전체 교정용 조성물 및 그 용도
|
US9963719B1
(en)
|
2016-12-05 |
2018-05-08 |
Editas Medicine, Inc. |
Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA
|